Comparison of acute and chronic glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, and metformin, in rat models of type 2 diabetes

被引：0
|
作者：
Yoshida, Taishi
Takahashi, Kanako
Nakashima, Ryutaro
Kanda, Shoichi
Okuno, Akira
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 47 条
  • [21] Glucose lowering and antidiabetic activity of a potent and selective inhibitor of fructose 1,6-bisphosphatase (MB06322) in normal and diabetic rodents
    Potter, SC
    van Poelje, PD
    Fujitaki, JM
    Pankop, M
    Dang, Q
    Erion, MD
    DIABETOLOGIA, 2004, 47 : A70 - A71
  • [22] DUAL ROLE OF ZN-2+ AS INHIBITOR AND ACTIVATOR OF FRUCTOSE 1,6-BISPHOSPHATASE OF RAT-LIVER
    TEJWANI, GA
    PEDROSA, FO
    PONTREMOLI, S
    HORECKER, BL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (08) : 2692 - 2695
  • [23] Pronounced and rapid glucose lowering with the fructose-1,6-bisphosphatase (FBPase) inhibitor MB07803 in poorly controlled type 2 diabetes mellitus (T2DM) subjects
    Gumbiner, B.
    Watling, S.
    Milad, M.
    Stern, T.
    Longcore, A.
    Le, T.
    Fereshetian, A.
    Foyt, H.
    Erion, M.
    DIABETOLOGIA, 2009, 52 : S343 - S343
  • [24] Molecular Docking of South Sulawesi Propolis against Fructose 1,6-Bisphosphatase as a Type 2 Diabetes Mellitus Drug
    Sahlan, Muhamad
    Al Faris, Muhammad Nizar Hamzah
    Aditama, Reza
    Lischer, Kenny
    Khayrani, Apriliana Cahya
    Pratami, Diah Kartika
    INTERNATIONAL JOURNAL OF TECHNOLOGY, 2020, 11 (05) : 910 - 920
  • [25] Additive glucose-lowering effects of GLP-1 and metformin in type 2 diabetes.
    Zander, M
    Madsbad, S
    Holst, JJ
    DIABETOLOGIA, 2000, 43 : A185 - A185
  • [26] Effect of MB06322, a potent and selective inhibitor of fructose 1,6-bisphosphatase, on gluconeogenesis in the ZDF rat as assessed by the deuterated water technique
    Potter, SC
    Chandramouli, V
    Landau, BR
    Linemeyer, DL
    Erion, MD
    Van Poelje, PD
    DIABETES, 2004, 53 : A364 - A364
  • [27] Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes
    Zander, M
    Taskiran, M
    Toft-Nielsen, MB
    Madsbad, S
    Holst, JJ
    DIABETES CARE, 2001, 24 (04) : 720 - 725
  • [28] Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis
    Gu, Shuyan
    Shi, Jihao
    Tang, Zhiliu
    Sawhney, Monika
    Hu, Huimei
    Shi, Lizheng
    Fonseca, Vivian
    Dong, Hengjin
    PLOS ONE, 2015, 10 (05):
  • [29] The acute glucose-lowering effect of metfomin in patients with type 2 diabetes is partly glucagon-like peptide-1-dependent
    Hansen, M.
    Bahne, E.
    Sonne, D. P.
    Rehfeld, J. F.
    Holst, J. J.
    Vilsboll, T.
    Knop, F. K.
    DIABETOLOGIA, 2015, 58 : S110 - S110
  • [30] High frequency of defecation under metformin use may be a potential glucose-lowering factor independent of the dosedependent effect of metformin in patients with type 2 diabetes mellitus
    Hieshima, Kunio
    Sugiyama, Seigo
    Yoshida, Akira
    Kurinami, Noboru
    Suzuki, Tomoko
    Miyamoto, Fumio
    Kajiwara, Keizo
    Jinnouchi, Katsunori
    Jinnouchi, Tomio
    Jinnouchi, Hideaki
    INTERNAL MEDICINE, 2024,
12345